Advanced search
Publication Cover
Open Access Rheumatology: Research and Reviews Volume 13, 2021 - Issue
Submit an article Journal homepage
147
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Improvement of HbA1c in Patients with Type 2 Diabetes Mellitus and Rheumatoid Arthritis Treated with bDMARDs

Alfredomaria Lurati1 Rheumatology Unit, Fornaroli Hospital Magenta Italy, Milan, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2784-9816View further author information
ORCID Icon,
Antonella Laria1 Rheumatology Unit, Fornaroli Hospital Magenta Italy, Milan, ItalyView further author information
,
Daniela Mazzocchi1 Rheumatology Unit, Fornaroli Hospital Magenta Italy, Milan, ItalyView further author information
,
Katia Angela Re1 Rheumatology Unit, Fornaroli Hospital Magenta Italy, Milan, ItalyView further author information
,
Maria Grazia Marrazza1 Rheumatology Unit, Fornaroli Hospital Magenta Italy, Milan, ItalyView further author information
,
Paola Maria Faggioli2 Internal Medicine Unit, Legnano Hospital, Milan, ItalyView further author information
&
Antonino Mazzone2 Internal Medicine Unit, Legnano Hospital, Milan, ItalyView further author information
 show all
Pages 73-78 | Published online: 28 Apr 2021

References

  • Solomon DH, Love TJ, Canning C, et al. Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis. Ann Rheum Dis. 2010;69:2114–2117. doi:10.1136/ard.2009.125476
  • Jin Y, Chen SK, Liu J, et al. Risk of incident type 2 diabetes mellitus among patients with rheumatoid arthritis: a population-based cohort study. Arthritis Care Res. 2020;72:1248–1256. doi:10.1002/acr.24343
  • Jiang P, Li H, Li X. Diabetes mellitus risk factors in rheumatoid arthritis: a systematic review and meta-analysis. Clin Exp Rheumatol. 2015;33:115–121.
  • Nicolau J, Lequerré T, Bacquet H, et al. Rheumatoid arthritis, insulin resistance, and diabetes. Joint Bone Spine. 2017;84:411–416. doi:10.1016/j.jbspin.2016.09.001
  • Emamifar A, Levin K, Jensen Hansen IM. Patients with newly diagnosed rheumatoid arthritis are at increased risk of diabetes mellitus: an observational cohort study. Acta Reumatol Port. 2017;42:310–317.
  • Solomon DH, Reed GW, Kremer JM, et al. Disease activity in rheumatoid arthritis and the risk of cardiovascular events. Arthritis Rheumatol. 2015;67:1449–1455. doi:10.1002/art.39098
  • Esser N, Legrand-Poels S, Piette J, et al. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014;105:141–150. doi:10.1016/j.diabres.2014.04.006
  • Wu H, Ballantyne CM. Skeletal muscle inflammation and insulin resistance in obesity. J Clin Invest. 2017;127:43–54. doi:10.1172/JCI88880
  • Solomon DH, Massarotti E, Garg R, et al. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. JAMA. 2011;305:2525–2531. doi:10.1001/jama.2011.878
  • Lillegraven S, Greenberg JD, Reed GW, et al. Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis. PLoS One. 2019;14(1):e0210459. doi:10.1371/journal.pone.0210459
  • Avina-Zubieta JA, Thomas J, Sadatsafavi M, et al. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012;71:1524–1529. doi:10.1136/annrheumdis-2011-200726
  • Peters MJ, van Halm VP, Voskuyl AE, et al. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. Arthritis Rheum. 2009;61:1571–1579. doi:10.1002/art.24836
  • van Halm VP, Peters MJ, Voskuyl AE, et al. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a crosssectional study, the CARRE Investigation. Ann Rheum Dis. 2009;68:1395–1400. doi:10.1136/ard.2008.094151
  • Innala L, Moller B, Ljung L, et al. Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Arthritis Res Ther. 2011;13:R131. doi:10.1186/ar3442
  • Peters MJ, Symmons DP, McCarey D, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis. 2010;69:325–331. doi:10.1136/ard.2009.113696
  • Lee BC, Lee J. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Biochim Biophys Acta. 2014;1842:446–462. doi:10.1016/j.bbadis.2013.05.017
  • Fujii M, Inoguchi T, Batchuluun B, et al. CTLA-4Ig immunotherapy of obesity-induced insulin resistance by manipulation of macrophage polarization in adipose tissues. Biochem Biophys Res Commun. 2013;438:103–109. doi:10.1016/j.bbrc.2013.07.034
  • Liu C, Feng X, Li Q, et al. Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: a systematic review and meta-analysis. Cytokine. 2016;86:100–109. doi:10.1016/j.cyto.2016.06.028
  • Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract. 2005;69:29–35. doi:10.1016/j.diabres.2004.11.007
  • Fève B, Bastard JP. The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol. 2009;5:305–311. doi:10.1038/nrendo.2009.62
  • Bastard JP, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006;17(1):4–12.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.